{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T11:29:56Z","timestamp":1789471796344,"version":"build-2803163510"},"reference-count":55,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,4,22]],"date-time":"2025-04-22T00:00:00Z","timestamp":1745280000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100006396","name":"Qazvin University of Medical Sciences","doi-asserted-by":"publisher","award":["400000605"],"award-info":[{"award-number":["400000605"]}],"id":[{"id":"10.13039\/501100006396","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ibroneuroreports.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["IBRO Neuroscience Reports"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.ibneur.2025.04.014","type":"journal-article","created":{"date-parts":[[2025,4,23]],"date-time":"2025-04-23T13:12:06Z","timestamp":1745413926000},"page":"672-678","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["The miR-133b and miR-206 serum levels as a candidate biomarker in Alzheimer's patients with dyslipidemia"],"prefix":"10.1016","volume":"18","author":[{"given":"Shahram","family":"Darabi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enam Alhagh","family":"Gorgich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8246-5631","authenticated-orcid":false,"given":"Auob","family":"Rustamzadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nafiseh","family":"Mohebi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hossein","family":"Mozhdehipanah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.ibneur.2025.04.014_bib1","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0090429","article-title":"Effects of blood contamination and the rostro-caudal gradient on the human cerebrospinal fluid proteome","volume":"9","author":"Aaseb\u00f8","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.ibneur.2025.04.014_bib2","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2019.00430","article-title":"Amyloid beta and microRNAs in Alzheimer\u2019s disease","volume":"13","author":"Amakiri","year":"2019","journal-title":"Front. Neurosci."},{"issue":"1","key":"10.1016\/j.ibneur.2025.04.014_bib3","doi-asserted-by":"crossref","first-page":"215","DOI":"10.3233\/JAD-160826","article-title":"Updating the evidence on the association between serum cholesterol and risk of late-life dementia: review and meta-analysis","volume":"56","author":"Anstey","year":"2017","journal-title":"J. Alzheimer'S. Dis."},{"issue":"5","key":"10.1016\/j.ibneur.2025.04.014_bib4","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1097\/01.JGP.0000310778.20870.ae","article-title":"Cholesterol as a risk factor for dementia and cognitive decline: a systematic review of prospective studies with meta-analysis","volume":"16","author":"Anstey","year":"2008","journal-title":"Am. J. Geriatr. Psychiatry"},{"issue":"3","key":"10.1016\/j.ibneur.2025.04.014_bib5","article-title":"Mini-mental state examination (MMSE) for the detection of Alzheimer's disease and other dementias in people with mild cognitive impairment (MCI)","author":"Arevalo-Rodriguez","year":"2015","journal-title":"Cochrane Database Syst. Rev."},{"issue":"10","key":"10.1016\/j.ibneur.2025.04.014_bib6","doi-asserted-by":"crossref","first-page":"880","DOI":"10.3390\/cells13100880","article-title":"BDNF modulation by microRNAs: an update on the experimental evidence","volume":"13","author":"Assis","year":"2024","journal-title":"Cells"},{"issue":"11","key":"10.1016\/j.ibneur.2025.04.014_bib7","doi-asserted-by":"crossref","DOI":"10.3390\/biom14111362","article-title":"Exploring the dynamic changes of brain lipids, lipid rafts, and lipid droplets in aging and Alzheimer's disease","volume":"14","author":"Cerasuolo","year":"2024","journal-title":"Biomolecules"},{"key":"10.1016\/j.ibneur.2025.04.014_bib8","article-title":"Smart chlorotoxin-functionalized liposomes for sunitinib targeted delivery into glioblastoma cells","volume":"77","author":"Charkhat Gorgich","year":"2022","journal-title":"J. Drug Deliv. Sci. Technol."},{"issue":"1","key":"10.1016\/j.ibneur.2025.04.014_bib9","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s13011-024-00591-0","article-title":"Brain-derived neurotrophic factor serum levels as a candidate biomarker for withdrawal in crack heroin dependence","volume":"19","author":"Charkhat Gorgich","year":"2024","journal-title":"Subst. Abus. Treat. Prev. Policy"},{"issue":"20","key":"10.1016\/j.ibneur.2025.04.014_bib10","doi-asserted-by":"crossref","DOI":"10.1093\/nar\/gni178","article-title":"Real-time quantification of microRNAs by stem-loop RT-PCR","volume":"33","author":"Chen","year":"2005","journal-title":"Nucleic Acids Res."},{"issue":"1","key":"10.1016\/j.ibneur.2025.04.014_bib11","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/s40035-020-00195-1","article-title":"Peripheral clearance of brain-derived A\u03b2 in Alzheimer's disease: pathophysiology and therapeutic perspectives","volume":"9","author":"Cheng","year":"2020","journal-title":"Transl. Neurodegener."},{"issue":"1","key":"10.1016\/j.ibneur.2025.04.014_bib12","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.neuron.2008.02.003","article-title":"Endocytosis is required for synaptic activity-dependent release of amyloid-\u03b2 in vivo","volume":"58","author":"Cirrito","year":"2008","journal-title":"Neuron"},{"key":"10.1016\/j.ibneur.2025.04.014_bib13","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2020.584606","article-title":"FAIM is regulated by MiR-206, MiR-1-3p and MiR-133b","volume":"8","author":"Coccia","year":"2020","journal-title":"Front. Cell Dev. Biol."},{"issue":"4","key":"10.1016\/j.ibneur.2025.04.014_bib14","doi-asserted-by":"crossref","first-page":"783","DOI":"10.3390\/diagnostics13040783","article-title":"CSF A\u03b242 and A\u03b242\/A\u03b240 ratio in Alzheimer\u2019s disease and frontotemporal dementias","volume":"13","author":"Constantinides","year":"2023","journal-title":"Diagnostics"},{"key":"10.1016\/j.ibneur.2025.04.014_bib15","doi-asserted-by":"crossref","first-page":"3","DOI":"10.61186\/phypha.29.1.3","article-title":"The pathophysiological signaling and efficacy ofmedicinal herbal compounds in Alzheimer\u2019s disease","volume":"29","author":"Darabi","year":"2025","journal-title":"Physiol. Pharmacol."},{"key":"10.1016\/j.ibneur.2025.04.014_bib16","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.ibneur.2025.01.004","article-title":"Lipidopathy disrupts peripheral and central amyloid clearance in Alzheimer\u2019s disease: where are our knowledge","volume":"18","author":"Darabi","year":"2025","journal-title":"IBRO Neurosci. Rep."},{"issue":"1","key":"10.1016\/j.ibneur.2025.04.014_bib17","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/s13195-022-00967-z","article-title":"The A\u03b21\u201342\/A\u03b21\u201340 ratio in CSF is more strongly associated to tau markers and clinical progression than A\u03b21\u201342 alone","volume":"14","author":"Delaby","year":"2022","journal-title":"Alzheimer'S. Res. Ther."},{"key":"10.1016\/j.ibneur.2025.04.014_bib18","doi-asserted-by":"crossref","first-page":"S196","DOI":"10.1016\/j.jalz.2014.04.015","article-title":"The critical need for defining preclinical biomarkers in Alzheimer's disease","volume":"10","author":"Fiandaca","year":"2014","journal-title":"Alzheimer'S. Dement."},{"issue":"10","key":"10.1016\/j.ibneur.2025.04.014_bib19","doi-asserted-by":"crossref","first-page":"2799","DOI":"10.1002\/acn3.52175","article-title":"miR-133b as a potential regulator of a synaptic NPTX2 protein in Alzheimer's disease","volume":"11","author":"Han","year":"2024","journal-title":"Ann. Clin. Transl. Neurol."},{"issue":"4","key":"10.1016\/j.ibneur.2025.04.014_bib20","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.3233\/JAD-170156","article-title":"Identification of circulating miR-125b as a potential biomarker of Alzheimer\u2019s disease in APP\/PS1 transgenic mouse","volume":"59","author":"Hong","year":"2017","journal-title":"J. Alzheimer'S. Dis."},{"key":"10.1016\/j.ibneur.2025.04.014_bib21","doi-asserted-by":"crossref","DOI":"10.1038\/s41398-019-0579-2","article-title":"A combined miRNA-piRNA signature to detect Alzheimer\u2019s disease","volume":"9","author":"Jain","year":"2019","journal-title":"Transl. Psychiatry"},{"issue":"4","key":"10.1016\/j.ibneur.2025.04.014_bib22","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1111\/j.1582-4934.2008.00313.x","article-title":"Biomarkers for early diagnosis of Alzheimer disease: \u2018ALZheimer associated gene\u2019\u2013a new blood biomarker?","volume":"12","author":"Jellinger","year":"2008","journal-title":"J. Cell. Mol. Med."},{"issue":"4","key":"10.1016\/j.ibneur.2025.04.014_bib23","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1111\/j.1600-0854.2006.00396.x","article-title":"Amyloid precursor protein and Notch intracellular domains are generated after transport of their precursors to the cell surface","volume":"7","author":"Kaether","year":"2006","journal-title":"Traffic"},{"issue":"5","key":"10.1016\/j.ibneur.2025.04.014_bib24","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/j.jalz.2015.12.012","article-title":"Validating Alzheimer's disease micro RNAs using next-generation sequencing","volume":"12","author":"Keller","year":"2016","journal-title":"Alzheimer'S. Dement."},{"issue":"11","key":"10.1016\/j.ibneur.2025.04.014_bib25","doi-asserted-by":"crossref","first-page":"734","DOI":"10.3390\/biom9110734","article-title":"Elevated plasma microRNA-206 levels predict cognitive decline and progression to dementia from mild cognitive impairment","volume":"9","author":"Kenny","year":"2019","journal-title":"Biomolecules"},{"key":"10.1016\/j.ibneur.2025.04.014_bib26","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2024.1325287","article-title":"The effect of human PBMCs immobilization on their \u0410\u03b242 aggregates-dependent proinflammatory state on a cellular model of Alzheimer's disease","volume":"18","author":"Kot","year":"2024","journal-title":"Front. Neurosci."},{"issue":"19","key":"10.1016\/j.ibneur.2025.04.014_bib27","doi-asserted-by":"crossref","first-page":"3808","DOI":"10.1093\/hmg\/ddx267","article-title":"MicroRNA-455-3p as a potential peripheral biomarker for Alzheimer\u2019s disease","volume":"26","author":"Kumar","year":"2017","journal-title":"Hum. Mol. Genet."},{"issue":"6","key":"10.1016\/j.ibneur.2025.04.014_bib28","doi-asserted-by":"crossref","first-page":"1642","DOI":"10.3390\/jcm9061642","article-title":"Downregulated platelet mir-1233-5p in patients with alzheimer\u2019s pathologic change with mild cognitive impairment is associated with a\u03b2-induced platelet activation via p-selectin","volume":"9","author":"Lee","year":"2020","journal-title":"J. Clin. Med."},{"issue":"1","key":"10.1016\/j.ibneur.2025.04.014_bib29","article-title":"The common Alzheimer's disease research ontology (CADRO) for biomarker categorization","volume":"11","author":"Leisgang Osse","year":"2025","journal-title":"Alzheimers Dement."},{"issue":"6","key":"10.1016\/j.ibneur.2025.04.014_bib30","doi-asserted-by":"crossref","first-page":"8908","DOI":"10.1002\/jcb.28361","article-title":"New insights into the role of microRNAs and long noncoding RNAs in most common neurodegenerative diseases","volume":"120","author":"Maniati","year":"2019","journal-title":"J. Cell. Biochem."},{"key":"10.1016\/j.ibneur.2025.04.014_bib31","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.pneurobio.2017.03.004","article-title":"Linking deregulation of non-coding RNA to the core pathophysiology of Alzheimer\u2019s disease: an integrative review","volume":"156","author":"Millan","year":"2017","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.ibneur.2025.04.014_bib32","doi-asserted-by":"crossref","DOI":"10.1016\/j.ibneur.2024.02.007","article-title":"Which neuroimaging and fluid biomarkers method is better in theranostic of Alzheimer\u2019s disease? An umbrella review","author":"Mohammadi","year":"2024","journal-title":"IBRO Neurosci. Rep."},{"issue":"2","key":"10.1016\/j.ibneur.2025.04.014_bib33","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.neuron.2014.12.032","article-title":"Blood-brain barrier breakdown in the aging human hippocampus","volume":"85","author":"Montagne","year":"2015","journal-title":"Neuron"},{"issue":"1","key":"10.1016\/j.ibneur.2025.04.014_bib34","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/s43856-024-00682-w","article-title":"Consuming a modified Mediterranean ketogenic diet reverses the peripheral lipid signature of Alzheimer's disease in humans","volume":"5","author":"Neth","year":"2025","journal-title":"Commun. Med."},{"key":"10.1016\/j.ibneur.2025.04.014_bib35","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1186\/1741-7015-7-66","article-title":"Accumulation of neutral lipids in peripheral blood mononuclear cells as a distinctive trait of Alzheimer patients and asymptomatic subjects at risk of disease","volume":"7","author":"Pani","year":"2009","journal-title":"BMC Med."},{"issue":"7","key":"10.1016\/j.ibneur.2025.04.014_bib36","doi-asserted-by":"crossref","first-page":"630","DOI":"10.2174\/1570159X16666180926123722","article-title":"Omics-based biomarkers for the early Alzheimer disease diagnosis and reliable therapeutic targets development","volume":"17","author":"Pe\u00f1a-Bautista","year":"2019","journal-title":"Curr. Neuropharmacol."},{"key":"10.1016\/j.ibneur.2025.04.014_bib37","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.arr.2018.11.005","article-title":"MicroRNAs and mild cognitive impairment: a systematic review","volume":"50","author":"Piscopo","year":"2019","journal-title":"Ageing Res. Rev."},{"issue":"8","key":"10.1016\/j.ibneur.2025.04.014_bib38","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/S1474-4422(05)70141-1","article-title":"The age-dependent relation of blood pressure to cognitive function and dementia","volume":"4","author":"Qiu","year":"2005","journal-title":"Lancet Neurol."},{"issue":"3","key":"10.1016\/j.ibneur.2025.04.014_bib39","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1159\/000115847","article-title":"Plasma lipid levels in the elderly are not associated with the risk of mild cognitive impairment","volume":"25","author":"Reitz","year":"2008","journal-title":"Dement. Geriatr. Cogn. Disord."},{"key":"10.1016\/j.ibneur.2025.04.014_bib40","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.neuint.2017.08.007","article-title":"APP\/A\u03b2 structural diversity and Alzheimer's disease pathogenesis","volume":"110","author":"Roher","year":"2017","journal-title":"Neurochem. Int."},{"issue":"6","key":"10.1016\/j.ibneur.2025.04.014_bib41","doi-asserted-by":"crossref","first-page":"4890","DOI":"10.3892\/mmr.2020.11538","article-title":"miR\u2011124\u20113p regulates angiogenesis in peripheral arterial disease by targeting STAT3","volume":"22","author":"Shi","year":"2020","journal-title":"Mol. Med. Rep."},{"issue":"3","key":"10.1016\/j.ibneur.2025.04.014_bib42","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1016\/j.neuron.2014.10.038","article-title":"The evolution of preclinical Alzheimer\u2019s disease: implications for prevention trials","volume":"84","author":"Sperling","year":"2014","journal-title":"Neuron"},{"key":"10.1016\/j.ibneur.2025.04.014_bib43","doi-asserted-by":"crossref","first-page":"6156","DOI":"10.1007\/s12035-019-1500-y","article-title":"Systematic review of miRNA as biomarkers in Alzheimer\u2019s disease","volume":"56","author":"Swarbrick","year":"2019","journal-title":"Mol. Neurobiol."},{"issue":"11","key":"10.1016\/j.ibneur.2025.04.014_bib44","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1016\/j.jalz.2019.06.4952","article-title":"Differential expression of microRNAs in Alzheimer's disease brain, blood, and cerebrospinal fluid","volume":"15","author":"Takousis","year":"2019","journal-title":"Alzheimer'S. Dement."},{"issue":"7","key":"10.1016\/j.ibneur.2025.04.014_bib45","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.3390\/ijms18071510","article-title":"miR-206-3p inhibits 3T3-L1 cell adipogenesis via the c-Met\/PI3K\/Akt pathway","volume":"18","author":"Tang","year":"2017","journal-title":"Int. J. Mol. Sci."},{"issue":"5","key":"10.1016\/j.ibneur.2025.04.014_bib46","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1038\/s41374-018-0169-6","article-title":"miR-483-5p decreases the radiosensitivity of nasopharyngeal carcinoma cells by targeting DAPK1","volume":"99","author":"Tian","year":"2019","journal-title":"Lab. Investig."},{"issue":"22","key":"10.1016\/j.ibneur.2025.04.014_bib47","doi-asserted-by":"crossref","first-page":"16259","DOI":"10.3390\/ijms242216259","article-title":"Potential implications of miRNAs in the pathogenesis, diagnosis, and therapeutics of Alzheimer\u2019s disease","volume":"24","author":"Wang","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"8","key":"10.1016\/j.ibneur.2025.04.014_bib48","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1007\/s11064-024-04174-0","article-title":"miR-206-3p targets brain-derived neurotrophic factor and affects postoperative cognitive function in aged mice","volume":"49","author":"Wang","year":"2024","journal-title":"Neurochem. Res"},{"issue":"3","key":"10.1016\/j.ibneur.2025.04.014_bib49","doi-asserted-by":"crossref","first-page":"875","DOI":"10.3233\/JAD-180539","article-title":"Validation of microRNA biomarkers for Alzheimer\u2019s disease in human cerebrospinal fluid","volume":"67","author":"Wiedrick","year":"2019","journal-title":"J. Alzheimer'S. Dis."},{"issue":"2","key":"10.1016\/j.ibneur.2025.04.014_bib50","doi-asserted-by":"crossref","first-page":"509","DOI":"10.3233\/JAD-160468","article-title":"Increased serum miR-206 level predicts conversion from amnestic mild cognitive impairment to Alzheimer\u2019s disease: a 5-year follow-up study","volume":"55","author":"Xie","year":"2017","journal-title":"J. Alzheimer'S. Dis."},{"issue":"2","key":"10.1016\/j.ibneur.2025.04.014_bib51","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.3892\/mmr.2016.5369","article-title":"Upregulation of microRNA-206 enhances lipopolysaccharide-induced inflammation and release of amyloid-\u03b2 by targeting insulin-like growth factor 1 in microglia","volume":"14","author":"Xing","year":"2016","journal-title":"Mol. Med. Rep."},{"issue":"12","key":"10.1016\/j.ibneur.2025.04.014_bib52","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0115293","article-title":"Universal stem-loop primer method for screening and quantification of microRNA","volume":"9","author":"Yang","year":"2014","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.ibneur.2025.04.014_bib53","first-page":"2711","article-title":"miR\u2011133b is a potential diagnostic biomarker for Alzheimer's disease and has a neuroprotective role","volume":"18","author":"Yang","year":"2019","journal-title":"Exp. Ther. Med."},{"issue":"6","key":"10.1016\/j.ibneur.2025.04.014_bib54","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1111\/febs.16344","article-title":"Lipid metabolism and Alzheimer's disease: clinical evidence, mechanistic link and therapeutic promise","volume":"290","author":"Yin","year":"2023","journal-title":"FEBS J."},{"key":"10.1016\/j.ibneur.2025.04.014_bib55","article-title":"The role of non-coding RNAs in Alzheimer's disease: from regulated mechanism to therapeutic targets and diagnostic biomarkers","volume":"13","author":"Zhang","year":"2021","journal-title":"Front. Aging Neurosci."}],"container-title":["IBRO Neuroscience Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2667242125000624?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2667242125000624?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,18]],"date-time":"2026-07-18T07:40:42Z","timestamp":1784360442000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2667242125000624"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":55,"alternative-id":["S2667242125000624"],"URL":"https:\/\/doi.org\/10.1016\/j.ibneur.2025.04.014","relation":{},"ISSN":["2667-2421"],"issn-type":[{"value":"2667-2421","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The miR-133b and miR-206 serum levels as a candidate biomarker in Alzheimer's patients with dyslipidemia","name":"articletitle","label":"Article Title"},{"value":"IBRO Neuroscience Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ibneur.2025.04.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Inc. on behalf of International Brain Research Organization.","name":"copyright","label":"Copyright"}]}}